Obesity: Molecular Physiology and Genetics of the Control of Body Weight

joint with Diabetes Mellitus: Molecular Mechanisms, Genetics and New Therapies

Organizer(s): Rudolph L. Leibel and Joel K. Elmquist

Sponsored by Biovitrum AB, Cell Press and Lilly Research Laboratories

Summary of Meeting:

The rapid increase in the prevalence of obesity in developed and developing countries constitutes a major threat to the health of individuals, and the medical economics of their countries. Obesity accounts for major fractions of type 2 diabetes, dyslipidemias, hypertension and stroke, and a growing proportion of certain cancers. The past decade has seen impressive advances in the elucidation of the molecular genetics and molecular physiology of the control of body weight and composition. However, this understanding has not yet been translated into successful preventive or therapeutic approaches to the disease. Likewise, the molecular bases for the relationship of obesity to most of the medical sequelae mentioned above remain unknown. The purpose of this meeting is to bring together scientists working on the molecular genetics and physiology of energy homeostasis with investigators seeking to understand aspects of the systemic physiology and environment that are interacting with clear genetic predisposition to increase the prevalence. Investigators have been selected for their contributions to the understanding of specific aspects of the molecular and systemic control of body weight, and the contributions of developmental and environmental factors, as well as for their interest in the functional mechanisms by which these interact.

Discounted Abstract Deadline: September 27 2004

Discounted Registration Deadline: November 29 2004

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Roche Palo Alto

We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1R13-DK070429-01

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations